Feasibility and acceptability of continuous postoperative pericardial flushing for blood loss reduction in patients undergoing coronary artery bypass grafting

被引:2
|
作者
Kara, Hakan [1 ]
Erden, Tuncay [2 ]
机构
[1] Giresun Ada Hosp, Dept Cardiovascular Surg, Giresun, Giresun, Turkey
[2] Karadeniz Syst Univ, Fac Med, Dept Cardiovascular Surg, Trabzon, Turkey
关键词
Continuous postoperative pericardial flushing; Coronary artery bypass grafting surgery; Postoperative hemorrhage; Cardiac tamponade; Chest tube; CARDIAC-SURGERY; RE-EXPLORATION; TAMPONADE; COST;
D O I
10.1007/s11748-019-01174-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Postoperative bleeding requires blood transfusion and surgical re-exploration that can affect the short- and long-term postoperative outcomes. Interventions that can be used in the postoperative period to reduce blood loss should be developed. Continuous postoperative pericardial flushing (CPPF) with an irrigation solution may reduce blood loss by preventing the accumulation of clots. This study examined the feasibility and acceptability of CPPF for reducing bleeding after coronary artery bypass surgery. Methods This pilot study adopted a prospective and group comparison design. Between January and April 2018, 42 patients who underwent isolated coronary artery bypass surgery received CPPF from sternal closure up to 8 h postoperative. The mean actual blood loss in the CPPF group was compared to the mean of retrospectively group (n = 58). In the CPPF group, an extra infusion catheter was inserted through one of the tube incision holes and an irrigation solution (0.9% NaCl at 38 degrees C) was delivered to the pericardial cavity by using a volumetric pump. Safety aspects, feasibility issues, and complications were documented. The primary outcome was blood loss, and it was assessed 18 h after the surgery. Results CPPF was successfully completed in 40 patients (95.24%). Method-related complications were not observed. Feasibility was good in this experimental setting. Blood loss was lower in the CPPF group (257.24 mL) than non-CPPF group (p < 0.001). Conclusions CPPF after coronary artery bypass grafting surgery is safe, effective, feasible, and acceptable. However, standardized randomized clinical trials are necessary to draw definitive conclusions.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [41] Left Atrial Strain to Predict Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting
    Pastore, Maria Concetta
    Degiovanni, Anna
    Grisafi, Leonardo
    Renda, Giulia
    Sozzani, Martina
    Giordano, Andrea
    Salvatici, Cosimo
    Lorenz, Veronica
    Pierfelice, Francesca
    Cappelli, Clelia
    De Donno, Federica
    Focardi, Marta
    Ricci, Fabrizio
    Benedetto, Umberto
    Gallina, Sabina
    Cameli, Matteo
    Patti, Giuseppe
    CIRCULATION-CARDIOVASCULAR IMAGING, 2024, 17 (01) : E015969
  • [42] Socioeconomic deprivation is a predictor of poor postoperative cardiovascular outcomes in patients undergoing coronary artery bypass grafting
    Taylor, FC
    Ascione, R
    Rees, K
    Narayan, P
    Angelini, GD
    HEART, 2003, 89 (09) : 1062 - 1066
  • [43] Blood transfusion and increased hospital morbidity and mortality in patients undergoing coronary artery bypass grafting
    Tanganelli, V.
    Campos, I. C.
    Farsky, P. S.
    Egito, J. G. T.
    Maues, H. P.
    Mousinho, M. C. C.
    Martins, F. A.
    Munhoz, G.
    EUROPEAN HEART JOURNAL, 2015, 36 : 895 - 895
  • [44] Effect of Pleurotomy on Blood Loss During Coronary Artery Bypass Grafting
    Atay, Yuksel
    Yagdi, Tahir
    Engin, Cagatay
    Ayik, Fatih
    Oguz, Emrah
    Alayunt, Alp
    Ozbaran, Mustafa
    Durmaz, Isa
    JOURNAL OF CARDIAC SURGERY, 2009, 24 (02) : 122 - 126
  • [45] Validation of fentanyl pharmacokinetics in patients undergoing coronary artery bypass grafting
    Hudson, RJ
    Thomson, IR
    Henderson, BT
    Singh, K
    Harding, G
    Peterson, DJ
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2002, 49 (04): : 388 - 392
  • [46] Associated vascular lesions in patients undergoing coronary artery bypass grafting
    Cirillo, F
    Renzulli, A
    Leonardo, G
    Romano, G
    De Feo, M
    Della Corte, A
    Crescenzi, B
    Cotrufo, R
    ACTA CARDIOLOGICA, 2001, 56 (02) : 91 - 96
  • [47] Plasma magnesium concentration in patients undergoing coronary artery bypass grafting
    Kotlinska-Hasiec, Edyta
    Makara-Studzinska, Marta
    Czajkowski, Marek
    Rzecki, Ziemowit
    Olszewski, Krzysztof
    Stadnik, Adam
    Pilat, Jacek
    Rybojad, Beata
    Dabrowski, Wojciech
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2017, 24 (02) : 181 - 184
  • [48] Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting
    Barakat, Amr F.
    Saad, Marwan
    Abuzaid, Ahmed
    Mentias, Amgad
    Mahmoud, Ahmed
    Elgendy, Islam Y.
    ANNALS OF THORACIC SURGERY, 2016, 101 (02): : 818 - 825
  • [49] Burden of Tricuspid Regurgitation in Patients Undergoing Coronary Artery Bypass Grafting
    Haywood, Nathan
    Mehaffey, J. Hunter
    Chancellor, W. Zachary
    Beller, Jared P.
    Speir, Alan
    Quader, Mohammed
    Yarboro, Leora T.
    Teman, Nicholas R.
    Ailawadi, Gorav
    ANNALS OF THORACIC SURGERY, 2021, 111 (01): : 44 - 50
  • [50] Risk factors for stroke in patients undergoing coronary artery bypass grafting
    Mickleborough, LL
    Walker, PM
    Takagi, Y
    Ohashi, M
    Ivanov, J
    Tamariz, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (05): : 1250 - 1258